RESTATED AGREEMENT TOInhibikase Therapeutics, Inc. • September 15th, 2020 • Biological products, (no disgnostic substances) • Georgia
Company FiledSeptember 15th, 2020 Industry JurisdictionTHE AGREEMENT TO REPAY AN INDIVIDUAL LOAN (the “Agreement”) that was initially entered into on the 5th of February, 2020 is RESTATED this 13th day of June, 2020 (the “Effective Date”), into by and between Inhibikase Therapeutics, Inc., a Delaware corporation (“Corporation”) and Milton H. Werner, Ph.D., individually a resident of the State of Georgia (“the Individual“).
RESTATED AGREEMENT TOInhibikase Therapeutics, Inc. • July 23rd, 2020 • Biological products, (no disgnostic substances) • Georgia
Company FiledJuly 23rd, 2020 Industry JurisdictionTHE AGREEMENT TO REPAY AN INDIVIDUAL LOAN (the “Agreement”) that was initially entered into on the 5th of February, 2020 is RESTATED this 13th day of June, 2020 (the “Effective Date”), into by and between Inhibikase Therapeutics, Inc., a Delaware corporation (“Corporation”) and Milton H. Werner, Ph.D., individually a resident of the State of Georgia (“the Individual“).